The Neuro receives donation of $500,000 to fund the first National Bank Post-Doctoral Fellowship in stem cell research
The Montreal Neurological Institute and Hospital (The Neuro) and the Experimental Therapeutics Program (ETP) are pleased to acknowledge National Bank Financial Group for its $500,000 donation to The Neuro’s Thinking Ahead Campaign to create the National Bank Post-Doctoral Fellowship in Experimental Therapeutics. The first fellowship will fund a revolutionary stem cell research project that will ad
Dr. Brenda Milner, the Dorothy J. Killam Professor at the Montreal Neurological Institute, McGill University, has had an extraordinary influence on the shape of neuroscience. The origins of modern cognitive neuroscience of memory can be traced directly to her rigorous and imaginative studies. Dr. Milner's research focuses on cognitive function in the frontal and temporal lobes of humans.
About ALS Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a devastating neurodegenerative disease affecting between two and five people per 100,000. Approximately 2,500 - 3,000 Canadian adults currently live with ALS. 80% per cent of people with ALS die within two to five years of diagnosis. The major symptoms of ALS are muscle weakness and wasting, progressively wor
The story of Dr. Jekyll and Mr. Hyde, about the positive and negative aspects of the same person, could also apply to proteins. Cellular inhibitor of apoptosis proteins (IAPs), are known to have negative effects by promoting the development of many cancers.
Scotiabank today announced a donation of $500,000 to the Montreal Neurological Institute and Hospital’s (The Neuro) “Thinking Ahead” campaign, which will expand the hospital’s Multiple Sclerosis (MS) Clinic. The expanded facility will result in improved service and care for people with MS.
Statins, a commonly prescribed class of drugs used by millions worldwide to effectively lower blood cholesterol levels, may actually have a negative impact in Multiple Sclerosis (MS) patients treated with high daily dosages.
Cocaine is one of the oldest drugs known to humans, and its abuse has become widespread since the end of the 19th century. At the same time, we know rather little about its effects on the human brain or the mechanisms that lead to cocaine addiction.
Researchers at the Université de Montreal (UdeM) and the Montreal Neurological Institute (MNI), McGill University have discovered that cells which normally support nerve cell (neuron) survival also play an active and major role in the death of neurons in the eye. The findings, published this week in The Journal of Neuroscience, may lead to more streamlined therapies for a variety of acute and chro
Did you know? • Canadians have one of the highest rates of Multiple Sclerosis (MS) in the world. • MS is the most common neurological disease affecting young adults in Canada, and every day three more people in Canada are diagnosed with MS. • MS is most often diagnosed in young adults aged 15 to 40, but it can also affect children -- some as young as two years old.
Did you know that: • Approximately 100, 000 Canadians have Parkinson’s disease. • Symptoms of Parkinson’s disease generally appear around the age of 60, although they can also occur in younger people. • Parkinson’s disease was first described in 1817 by Dr. James Parkinson, a British physician, after whom the disease was named.
A collaborative study led by researchers at the Montreal Neurological Institute (MNI), McGill University has demonstrated a positive link between cognitive ability and cortical thickness in the brains of healthy 6 to 18 year olds.
Know Your Brain: Montreal universities, institutes and research centres team up for Brain Awareness Week (BAW)
Explore your brain with the experts. Montreal neuroscientists join forces this week to shed light on the grayest of matters - our gray matter - during the upcoming Brain Awareness Week (March 16-22).
Seizure-induced brain damage in epileptic patients: A new study published in Neurology by Dr. Neda Bernasconi and colleagues, reveals that patients with medication-resistant temporal lobe epilepsy (TLE), have progressive atrophy, or loss of cells, in some regions of the brain.
A new comprehensive review by researchers at the Montreal Neurological Institute (MNI), McGill University and the University of Cambridge, England provides vital insights into the neurological basis of addiction by investigating Parkinson’s disease patients, who in some instances develop various addictions when undergoing medical treatment. The review, published in this week’s (February 25) issue